Vistagen Therapeutics, Inc. (VTGN) stock
VTGNNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/3073% below fair value
$0.18+0.00 (+0.95%)
Close on Nov 13, 2026Market cap $8.01MP/E –Yield –
Vistagen Therapeutics statistics
71 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 11, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.53
- 2.22
Enterprise valuationIndustry
- EV / Sales
- -5.03
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 32.3%
- 10.8%
- Float
- 44M
- 49M
- Shares Held by Insiders
- 0.52%
- 11.7%
- Shares Held by Institutions
- 26.5%
- 56.4%
Short sellingIndustry
- Short Interest
- 2M
- –
- Short Interest Change
- 0.64%
- -0.80%
- Short % of Float
- 5.64%
- 9.01%
- Short % of Shares Outstanding
- 5.61%
- 6.30%
- Days to Cover
- 3.42
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $5.14
- –
- 52-Week Low
- $0.16
- –
- 20-Day Moving Average
- $0.18
- –
- 50-Day Moving Average
- $0.22
- –
- 200-Day Moving Average
- $0.42
- –
- Average True Range (14)
- $0.02
- –
- Price Change (1 Week)
- 10.2%
- -1.15%
- Price Change (1 Month)
- -15.3%
- -4.87%
- Price Change (3 Months)
- -30.6%
- -21.0%
- Price Change (6 Months)
- -71.1%
- -20.6%
- Price Change (YTD)
- -72.7%
- -23.6%
- Price Change (1 Year)
- -95.6%
- -22.4%
- Price Change (3 Years)
- -94.3%
- -29.5%
- Price Change (5 Years)
- -99.7%
- -77.9%
- Price Change (10 Years)
- -99.8%
- -65.4%
- Average Volume (10 Days)
- 737,287
- –
- Average Volume (20 Days)
- 747,125
- –
- Average Volume (90 Days)
- 9M
- –
- Relative Volume
- 0.05
- 0.70
- Relative Strength Index (14)
- 43.4
- 43.4
- Volatility (1 Year)
- 142.7%
- 80.1%
- Beta (5 Years)
- 1.31
- 1.07
MarginsIndustry
- Pretax Margin
- -2474.2%
- -11.6%
- EBITDA Margin
- -2533.2%
- -27.7%
Returns on capitalIndustry
- Return on Equity (ROE)
- -144.9%
- -49.9%
- Return on Assets (ROA)
- -113.0%
- -40.6%
- Return on Capital Employed (ROCE)
- -403.9%
- -37.9%
Financial positionIndustry
- Current Ratio
- 2.64
- 3.30
- Quick Ratio
- 2.37
- 2.39
GrowthIndustry
- Revenue Growth (5Y CAGR)
- 3.10%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.05
- 0.40
- Revenue Per Employee
- $58.10K
- $429.29K
- Profits Per Employee
- -$1.44M
- -$689.41K
- Employee Count
- 41
- 74
- WACC
- 11.6%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$58.94M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $20.00M
- $17.76M
- Net Cash Per Share
- $0.45
- $0.80
- Equity (Book Value)
- $14.99M
- $53.89M
- Book Value Per Share
- $0.34
- $1.50
- Tangible Book Value
- $14.99M
- $27.13M
- Working Capital
- $13.87M
- $79.99M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -735.9%
- -21.8%
Taxes and interestIndustry
- Income Tax
- $7.00K
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- -37.10
- 0.23
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | VTGN | S&P 500 | Difference | VTGN per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -16.0% | -3.0% | −12.9 pts | ||
| 3 months | -32.2% | -2.8% | −29.4 pts | ||
| Year to date | -72.7% | +11.5% | −84.2 pts | ||
| 1 year | -95.3% | +13.5% | −108.7 pts | ||
| 3 years | -93.4% | +77.7% | −171.1 pts | -59.6% | +21.1% |
| 5 years | -99.7% | +72.6% | −172.3 pts | -69.3% | +11.5% |
| 10 years | -99.8% | +308.2% | −408.0 pts | -47.5% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
2M VTGN shares were sold short on Oct 30, 2026, up 0.6% from the previous report, or 5.64% of the shares available to trade. At recent volumes it would take 3.4 days to buy them back. Over the last 20 sessions, 51.3% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 2,488,148 | +0.6% | 728,036 | 3.4 |
| Oct 15, 2026 | 2,472,435 | -34.1% | 1,137,394 | 2.2 |
| Sep 30, 2026 | 3,750,912 | +38.6% | 55,161,968 | 1.0 |
| Sep 15, 2026 | 2,707,020 | +27.3% | 354,148 | 7.6 |
| Aug 31, 2026 | 2,126,593 | +8.9% | 762,770 | 2.8 |
| Aug 14, 2026 | 1,952,907 | -2.6% | 13,056,772 | 1.0 |
| Jul 31, 2026 | 2,005,860 | +25.7% | 823,269 | 2.4 |
| Jul 15, 2026 | 1,596,248 | +0.3% | 3,306,171 | 1.0 |
| Jun 30, 2026 | 1,591,673 | -6.6% | 5,765,083 | 1.0 |
| Jun 15, 2026 | 1,705,050 | -15.6% | 705,956 | 2.4 |
| May 29, 2026 | 2,020,399 | +12.4% | 503,202 | 4.0 |
| May 15, 2026 | 1,797,894 | +2.2% | 1,120,681 | 1.6 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?